Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Paramount Bed Holdings Co's annualized net income for the quarter that ended in Sep. 2025 was 円5,148 Mil. Paramount Bed Holdings Co's average shareholder tangible equity for the quarter that ended in Sep. 2025 was 円130,179 Mil. Therefore, Paramount Bed Holdings Co's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2025 was 3.95%.
The historical rank and industry rank for Paramount Bed Holdings Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:7817'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 1.82 Med: 7.8 Max: 10.65
Current: 1.82
During the past 13 years, Paramount Bed Holdings Co's highest Return-on-Tangible-Equity was 10.65%. The lowest was 1.82%. And the median was 7.80%.
TSE:7817's Return-on-Tangible-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 4.055
vs TSE:7817: 1.82
Paramount Bed Holdings Co (TSE:7817) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Paramount Bed Holdings Co Return-on-Tangible-Equity Related Terms
Paramount Bed Holdings Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Paramount Bed Holdings Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co Return-on-Tangible-Equity Chart
TSE:7817 vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Sep. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 3.95% mean?
Paramount Bed Holdings Co (TSE:7817) has a Return-on-Tangible-Equity of 3.95% as of Sep. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Paramount Bed Holdings Co and its competitors. This is 49% below median its historical median of 7.80. Over the past decade, Paramount Bed Holdings Co's Return-on-Tangible-Equity has ranged from 1.82 to 10.65.
Is Paramount Bed Holdings Co's Return-on-Tangible-Equity too high?
Paramount Bed Holdings Co's current Return-on-Tangible-Equity of 3.95% is 49% below median its 10-year median of 7.80. Over the past 10 years, this metric has ranged from a low of 1.82 to a high of 10.65. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.06. Paramount Bed Holdings Co's value of 3.95% is 2.6% below this industry median. Overall, Paramount Bed Holdings Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's Return-on-Tangible-Equity compare to ISRG and BDX?
Paramount Bed Holdings Co's Return-on-Tangible-Equity of 3.95% can be compared against companies in the Medical Devices & Instruments industry. The industry median Return-on-Tangible-Equity is 4.06. Paramount Bed Holdings Co's value of 3.95% is 2.6% below this benchmark. Historically, Paramount Bed Holdings Co's own Return-on-Tangible-Equity has ranged from 1.82 to 10.65 over the past decade. While the company's 10-year median is 7.80 vs. the industry median of 4.06, Paramount Bed Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.06, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paramount Bed Holdings Co's current Return-on-Tangible-Equity of 3.95% is 2.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Paramount Bed Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current Return-on-Tangible-Equity is 3.95%, which is 49% below median its own 10-year median of 7.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (TSE:7817) has a current Return-on-Tangible-Equity of 3.95%. The stock's GF Value™ is 円2,907.43, compared to a current price of 円3,515.00 — trading 20.9% above its estimated fair value. The current Return-on-Tangible-Equity is 3.95%, which is 49% below median its 10-year median of 7.80 and 2.6% below the Medical Devices & Instruments industry median of 4.06. Paramount Bed Holdings Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Paramount Bed Holdings Co (TSE:7817), the current Return-on-Tangible-Equity is 3.95% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (TSE:7817) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of 円3,515.00 is trading 20.9% above its estimated GF Value™ of 円2,907.43.
Key valuation signals for TSE:7817:
Return-on-Tangible-Equity: 3.95% (49% below median its 10-year median of 7.80)
GF Value™: 円2,907.43 vs. price of 円3,515.00 (20.9% above fair value)
Industry Position: 2.6% below the Medical Devices & Instruments median
No single metric tells the full story. See the TSE:7817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
69GF Score
Get the complete analysis for TSE:7817
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7817 has been successfully added to your 
